BioCentury
ARTICLE | Clinical News

Pharmacia terminates leridistim

July 21, 2000 7:00 AM UTC

PHA discontinued its leridistim program to treat complications of chemotherapy following a review of a Phase III study in adult patients. Although the agent promoted neutrophil recovery, it produced a...